BRAHMI GHRITA NASYA AND GHRITAPANA IN MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SCHOOL GOING CHILDREN

EFFICACY OF BRAHMI GHRITA NASYA VS GHRITAPANA IN ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SCHOOLERS, A COMPARATIVE STUDY - NILL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086954

Enrollment

Registered

2025-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1- Children fulfilling the DSM- V criteria for diagnosis of ADHD. 2- School going children aged between 7-16 years of age with academically under achievements, poor concentration, increased distractibility, motor restlessness will be included in this study.

Exclusion criteria

Exclusion criteria: 1- Children not fulfilling the DSM- V criteria for diagnosis of ADHD. 2- Known cases of Cerebral palsy, Mental retardation and epilepsy. 3- Known cases of Hearing deficit. 4- Children with Obvious congenital anomalies like cleft palate, CHD etc. 5-Known cases of systemic disorders and metabolic disorders.

Design outcomes

Primary

Measure	Time frame
Reduced DSM-V ScoreTimepoint: After every 15 Days (From 0th, 15th, 30th, 45th and 60th day).	—

Secondary

Measure	Time frame
Reduced Inattention, Hyperactivity and Impulsivity Timepoint: After every 15 Days (From 0th, 15th, 30th, 45th and 60th day).	—

Countries

India

Contacts

Public ContactDr Kalpana Dattatray Dhuri

D.Y.Patil Deemed to be University, School of Ayurveda, Nerul, Navi Mumbai

kalpana.dhuri@dypatil.edu9321835616

Outcome results